Joseph C. Papa - 25 Jun 2025 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Joseph C. Papa
Issuer symbol
CADL
Transactions as of
25 Jun 2025
Net transactions value
+$299,996
Form type
4
Filing time
26 Jun 2025, 08:30:04 UTC
Previous filing
18 Jun 2025
Next filing
15 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PAPA JOSEPH C Director C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM /s/ Charles Schoch, as Attorney-In-Fact for Joseph C. Papa 26 Jun 2025 0001242215

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Award $299,996 +64,239 $4.67 64,239 25 Jun 2025 By Joseph C. Papa Revocable Living Trust F1, F2
holding CADL Common Stock 38,032 25 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.
F2 Shares held by Joseph C. Papa Revocable Living Trust, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.